Navigation Links
Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
Date:10/3/2007

-- Caliper Discovery Alliances & Services to Develop Customized Transgenic

and Knock-Out Mouse Models --

HOPKINTON, Mass., Oct. 3 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced that the National Institute of Environmental Health Services (NIEHS) has awarded the company a contract valued at up to $7.0 million covering a period of up to ten years at the option of NIEHS. Under the terms of the agreement, Xenogen Biosciences, the in vivo drug discovery services arm of Caliper Discovery Alliances & Services (CDAS), will supply numerous NIEHS investigators with genetically-modified mouse models for research purposes.

The NIEHS focuses its research on the environment and its impact on human health and disease. Working with genetically modified mouse models, including transgenic and gene knockout, enables NIEHS to conduct research aimed at identifying and potentially preventing hazardous conditions and exposure in humans. Beginning immediately, Caliper will develop unique mouse models based on the needs of the research teams at the NIEHS.

The business was awarded to Caliper through a competitive bid process and reflects the company's expertise and proven ability to design and produce genetic modifications in mice. Caliper has produced more than 9,000 unique mouse and rat models, some of which were previously supplied to the NIEHS under the terms of a previous multi-year agreement.

"This contract is the second significant win for our services business in recent months, following the in vitro Environmental Protection Agency contract announced earlier in the second quarter," said Kevin Hrusovsky, CEO of Caliper Life Sciences. "Our contract with the NIEHS builds on our existing relationship with this organization and further validates the capabilities of our services organization and the increasing industry demand that is fueling our growth."

Caliper Discovery Alliances & Services (CDAS) is the services organization created from the integration of NovaScreen Biosciences, a provider of in vitro discovery services, and Xenogen Biosciences, a provider of in vivo discovery services. NovaScreen was acquired by Caliper in October 2005 and Xenogen was acquired by Caliper in August 2006. CDAS provides a wide range of in vitro and in vivo products and services that enable biotechnology and pharmaceutical companies to reduce costs while accelerating the pace and clinical relevance of drug research.

About Caliper Life Sciences

Caliper Life Sciences is a leading provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com .

Caliper and Xenogen are registered trademarks of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Automation of the Eppendorf Perfectprep BAC 96 DNA Kit on the Caliper Life Sciences Sciclone ALH 3000
2. Perscitus Biosciences secures $250K Commerce loan
3. Wisconsin biosciences rise to the challenge
4. Wisconsin professors elected to National Academy of Sciences
5. Quintessence Biosciences advances cancer drug
6. Quintessence Biosciences names new president
7. InvivoSciences receives NIH grant for heart technology
8. Caden Biosciences may signal critical mass
9. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
10. QBI Life Sciences snags $130,000 NIH grant
11. WARF signs licensing pact with BD Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... (PRWEB) , ... April 27, 2016 , ... ... Touch screen mobile devices with fingerprint recognition for secure access, voice recognition ... only a few ways consumers are interacting with biometrics technology today. But ...
(Date:4/27/2016)... ... 2016 , ... PathSensors, Inc., a leading environmental testing company, ... assist PathSensors in expanding the use of the company’s CANARY® technology in the ... for the detection of harmful pathogens, including a number of bacteria, viruses, toxins, ...
(Date:4/27/2016)... , April 27, 2016 ... research report with specific focus on US, EU, ... Japan , to the healthcare business intelligence ... library. Complete report on the Flow ... companies and supported with 282 tables and figures ...
(Date:4/26/2016)... , ... April 26, 2016 , ... Mr. Palmer created ... RPO, signing the first multi-million dollar, multi-year managed services contract in the U.S. intelligence ... Michael join our leadership team,” said John Younger, founder of Accolo. “We are ...
Breaking Biology Technology:
(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
(Date:3/18/2016)... --> --> ... & Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance & Detection ... border security market and the continuing migration crisis in the ... has led visiongain to publish this unique report, ... defence & security companies in the border security ...
Breaking Biology News(10 mins):